MET METLIFE INC
Life Insurance · NYSE · SEC CIK 1099219 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $20.52B | $19.15B | $19.07B | $23.81B | $17.36B | $17.34B | $18.57B | $18.67B |
| SG&A expense | $139.00M | $154.00M | $132.00M | $186.00M | $118.00M | $130.00M | $126.00M | $18.00M |
| Operating income | $1.83B | $1.60B | $1.63B | $1.68B | $1.65B | $1.39B | $1.42B | $1.49B |
| Interest expense | $291.00M | $292.00M | $265.00M | -$74.00M | $271.00M | $269.00M | $258.00M | -$40.00M |
| Pretax income | $3.00B | $1.03B | $1.51B | $1.12B | $1.21B | $980.00M | $1.35B | $1.38B |
| Income tax | $588.00M | $256.00M | $345.00M | $301.00M | $308.00M | $245.00M | $404.00M | $106.00M |
| Net income | $2.40B | $736.00M | $1.19B | $809.00M | $896.00M | $729.00M | $945.00M | $1.27B |
| EBITDA | $1.86B | $1.64B | $1.66B | $1.71B | $1.68B | $1.42B | $1.44B | $1.52B |
| EPS (basic) | 3.70 | 1.10 | 1.75 | — | 1.23 | 1.04 | 1.29 | — |
| EPS (diluted) | 3.67 | 1.09 | 1.74 | — | 1.22 | 1.03 | 1.28 | — |
| Dividends declared per share | 0.59 | 0.59 | 0.57 | 0.57 | 0.57 | 0.57 | 0.55 | 0.54 |
| Weighted avg. shares (diluted) | 639.90M | 646.90M | 655.70M | — | 669.10M | 675.00M | 687.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $19.79B | $19.30B | $22.69B | $22.03B | $20.23B | $22.18B | $21.33B | $20.07B |
| Short-term investments | $7.88B | $8.02B | $4.95B | $3.60B | $5.96B | $5.30B | $5.54B | $5.16B |
| Goodwill | $9.54B | $9.54B | $9.56B | $9.61B | $9.10B | $9.14B | $9.04B | $8.90B |
| Intangibles | — | — | — | $636.00M | — | — | — | $710.00M |
| Total assets | $744.61B | $759.37B | $743.21B | $745.17B | $719.73B | $702.47B | $688.32B | $677.46B |
| Short-term debt | $289.00M | $460.00M | $404.00M | $355.00M | $378.00M | $379.00M | $381.00M | $465.00M |
| Total liabilities | $721.89B | $731.41B | $715.41B | $716.25B | $690.53B | $674.54B | $660.56B | $649.75B |
| Shareholders' equity | $22.23B | $27.44B | $27.32B | $28.40B | $28.94B | $27.68B | $27.49B | $27.45B |
| Shares outstanding | 631.11M | 637.75M | 646.02M | 655.33M | 660.72M | 666.83M | 673.29M | 689.21M |
| Cash flow statement | ||||||||
| Operating cash flow | $2.00B | $2.23B | $2.69B | $7.08B | $3.57B | $2.19B | $4.26B | $4.61B |
| Investing cash flow | -$3.50B | -$8.87B | -$5.46B | -$4.29B | -$5.02B | -$2.98B | -$3.32B | -$5.36B |
| Financing cash flow | $2.03B | $3.22B | $3.56B | -$998.00M | -$508.00M | $1.45B | $220.00M | -$519.00M |
| Depreciation & amortization | $31.00M | $40.00M | $29.00M | $30.00M | $30.00M | $28.00M | $29.00M | $33.00M |
| Dividends paid | $379.00M | $383.00M | $372.00M | $375.00M | $378.00M | $382.00M | $374.00M | $378.00M |
| Share buybacks | $651.00M | $722.00M | $755.00M | $460.00M | $502.00M | $510.00M | $1.41B | $406.00M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.